{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T03:48:29Z","timestamp":1788407309071,"version":"build-2803163510"},"reference-count":201,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,6,4]],"date-time":"2015-06-04T00:00:00Z","timestamp":1433376000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","atherosclerosis-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.atherosclerosis.2015.05.038","type":"journal-article","created":{"date-parts":[[2015,6,6]],"date-time":"2015-06-06T22:57:33Z","timestamp":1433631453000},"page":"480-494","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":97,"title":["The complement system and toll-like receptors as integrated players in the pathophysiology of atherosclerosis"],"prefix":"10.1016","volume":"241","author":[{"given":"Anders","family":"Hovland","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Jonasson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Garred","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arne","family":"Yndestad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e5l","family":"Aukrust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Knut T.","family":"Lappeg\u00e5rd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terje","family":"Espevik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom E.","family":"Mollnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib1","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1161\/CIR.0b013e31820a55f5","article-title":"Council on cardiovascular surgery and anesthesia, and interdisciplinary council on quality of care and outcomes research. Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association","volume":"123","author":"Heidenreich","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib2","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/nri1882","article-title":"The immune response in atherosclerosis: a double-edged sword","volume":"6","author":"Hansson","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib3","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/ni.2001","article-title":"The immune system in atherosclerosis","volume":"12","author":"Hansson","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib4","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1038\/nm1102-1211","article-title":"Atherogenesis in perspective: hypercholesterolemia and inflammation as partners in crime","volume":"8","author":"Steinberg","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib5","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/nature00804","article-title":"Subendothelial retention of atherogenic lipoproteins in early atherosclerosis","volume":"417","author":"Sk\u00e5len","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib6","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1161\/CIRCULATIONAHA.106.676890","article-title":"Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications","volume":"116","author":"Tabas","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib7","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1161\/ATVBAHA.110.207415","article-title":"Recent advances on the role of cytokines in atherosclerosis","volume":"31","author":"Ait-Oufella","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib8","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0021-9150(99)00011-8","article-title":"Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines","volume":"145","author":"Frosteg\u00e5rd","year":"1999","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib9","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/MOL.0b013e32834adaf3","article-title":"Current understanding of the role of B cell subsets and intimal and adventitial B cells in atherosclerosis","volume":"22","author":"Kyaw","year":"2011","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib10","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.vph.2012.01.009","article-title":"Humoral and cellular immune responses in atherosclerosis: spotlight on B- and T-cells","volume":"56","author":"Ponnuswamy","year":"2012","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib11","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1016\/j.cca.2012.04.031","article-title":"Lymphocytes in atherosclerosis","volume":"413","author":"Wigren","year":"2012","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib12","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/imr.12218","article-title":"Macrophage phenotypes in atherosclerosis","volume":"262","author":"Colin","year":"2014","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib13","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s40169-014-0042-1","article-title":"Clinical significance of macrophage phenotypes in cardiovascular disease","volume":"3","author":"Medbury","year":"2014","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib14","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/nri2448","article-title":"Exploring the full spectrum of macrophage activation","volume":"8","author":"Mosser","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib15","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1161\/CIRCRESAHA.111.247577","article-title":"Activating transcription factor 1 directs Mhem atheroprotective macrophages through coordinated iron handling and foam cell protection","volume":"110","author":"Boyle","year":"2012","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib16","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1177\/1753425914526461","article-title":"CXCL4-induced plaque macrophages can be specifically identified by co-expression of MMP7+S100A8+ in\u00a0vitro and in\u00a0vivo","volume":"21","author":"Erbel","year":"2015","journal-title":"Innate Immun."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib17","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1161\/ATVBAHA.114.304927","article-title":"Complement-mediated macrophage polarization in perivascular adipose tissue contributes to vascular injury in deoxycorticosterone acetate-salt mice","volume":"35","author":"Ruan","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib18","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1038\/nm.2538","article-title":"Atherosclerosis: current pathogenesis and therapeutic options","volume":"17","author":"Weber","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib19","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1161\/01.ATV.0000166518.96137.38","article-title":"Humoral immune response against defined oxidized low-density lipoprotein antigens reflects structure and disease activity of carotid plaques","volume":"25","author":"Gon\u00e7alves","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"Suppl.\u00a0l","key":"10.1016\/j.atherosclerosis.2015.05.038_bib20","doi-asserted-by":"crossref","first-page":"S388","DOI":"10.1194\/jlr.R800100-JLR200","article-title":"The role of innate immunity in atherogenesis","volume":"50","author":"Hartvigsen","year":"2009","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib21","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.immuni.2012.08.002","article-title":"Regulation of humoral immunity by complement","volume":"37","author":"Carroll","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib22","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.smim.2013.04.012","article-title":"The role of complement in CD4(+) T cell homeostasis and effector functions","volume":"25","author":"Kolev","year":"2013","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib23","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.atherosclerosis.2009.09.075","article-title":"Toll like receptor 4 in atherosclerosis and plaque destabilization","volume":"209","author":"den Dekker","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib24","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/MOL.0b013e32834ada80","article-title":"Innate immune recognition receptors and damage-associated molecular patterns in plaque inflammation","volume":"22","author":"Lundberg","year":"2011","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib25","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1161\/CIRCRESAHA.110.226936","article-title":"The emerging role of innate immunity in the heart and vascular system: for whom the cell tolls","volume":"108","author":"Mann","year":"2011","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib26","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.cca.2011.08.021","article-title":"Toll-like receptors and macrophage activation in atherosclerosis","volume":"413","author":"Seneviratne","year":"2012","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib27","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/MOL.0b013e32830f4a06","article-title":"The role of complement in atherosclerosis","volume":"19","author":"Haskard","year":"2008","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib28","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.atherosclerosis.2009.07.030","article-title":"Coronary late lumen loss of drug eluting stents is associated with increased serum levels of the complement components C3a and C5a","volume":"208","author":"Speidl","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib29","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.clinbiochem.2012.09.012","article-title":"Complement and atherosclerosis-united to the point of no return?","volume":"46","author":"Torzewski","year":"2013","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib30","first-page":"462","article-title":"Les leukocytes et les proprietes actives du serum chez les vaccines","volume":"9","author":"Bordet","year":"1895","journal-title":"Ann. Inst. Pasteur"},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib31","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1056\/NEJM200104053441406","article-title":"Complement. First of two parts","volume":"344","author":"Walport","year":"2001","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib32","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1056\/NEJM200104123441506","article-title":"Complement. Second of two parts","volume":"344","author":"Walport","year":"2001","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib33","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/ni.1923","article-title":"Complement: a key system for immune surveillance and homeostasis","volume":"11","author":"Ricklin","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib34","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0021-9150(73)90117-2","article-title":"Complement and arteriosclerosis","volume":"18","author":"Geertinger","year":"1973","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib35","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0021-9150(88)90030-5","article-title":"The complement system in atherosclerosis","volume":"73","author":"Seifert","year":"1988","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib36","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1016\/j.molimm.2009.05.005","article-title":"MBL2, FCN1, FCN2 and FCN3-The genes behind the initiation of the lectin pathway of complement","volume":"46","author":"Garred","year":"2009","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib37","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1159\/000345356","article-title":"Collectin-11\/MASP complex formation triggers activation of the lectin complement pathway\u2013the fifth lectin pathway initiation complex","volume":"5","author":"Ma","year":"2013","journal-title":"J.\u00a0Innate Immun."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj2640001","article-title":"Complement membrane attack on nucleated cells: resistance, recovery and non-lethal effects","volume":"264","author":"Morgan","year":"1989","journal-title":"Biochem. J."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib39","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nm1419","article-title":"Generation of C5a in the absence of C3: a new complement activation pathway","volume":"12","author":"Huber-Lang","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib40","doi-asserted-by":"crossref","first-page":"3125","DOI":"10.1016\/j.molimm.2008.03.008","article-title":"Evidence for non-traditional activation of complement factor C3 during murine liver regeneration","volume":"45","author":"Clark","year":"2008","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib41","first-page":"68","article-title":"Interaction between the coagulation and complement system","author":"Amara","year":"2009","journal-title":"Curr. Top. Complement II"},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib42","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1182\/blood-2012-02-412080","article-title":"Thrombin generates previously unidentified C5 products that support the terminal complement activation pathway","volume":"120","author":"Krisinger","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib43","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1084\/jem.20070664","article-title":"Complement factor H and the hemolytic uremic syndrome","volume":"204","author":"Atkinson","year":"2007","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib44","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1532\/IJH97.06117","article-title":"Recent advances in biological and clinical aspects of paroxysmal nocturnal hemoglobinuria","volume":"84","author":"Luzzatto","year":"2006","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib45","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1398-9995.2011.02751.x","article-title":"HAWK (Hereditary Angioedema International Working Group). Evidence-based recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency: consensus report of an International Working Group","volume":"67","author":"Cicardi","year":"2012","journal-title":"Allergy"},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib46","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/MOH.0b013e328351c348","article-title":"Paroxysmal nocturnal hemoglobinuria","volume":"19","author":"Parker","year":"2012","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib47","doi-asserted-by":"crossref","first-page":"15861","DOI":"10.1073\/pnas.0903613106","article-title":"Human genetic deficiencies reveal the roles of complement in the inflammatory network: lessons from nature","volume":"106","author":"Lappeg\u00e5rd","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib48","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.imbio.2013.04.021","article-title":"Primary complement C5 deficiencies - molecular characterization and clinical review of two families","volume":"218","author":"Schejbel","year":"2013","journal-title":"Immunobiology"},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib49","doi-asserted-by":"crossref","first-page":"3839","DOI":"10.4049\/jimmunol.1203200","article-title":"Complement in immune and inflammatory disorders: therapeutic interventions","volume":"190","author":"Ricklin","year":"2013","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib50","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1126\/science.2371562","article-title":"Soluble human complement receptor type 1: in\u00a0vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis","volume":"249","author":"Weisman","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib51","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.jtcvs.2007.12.062","article-title":"Pexelizumab in ischemic heart disease: a systematic review and meta-analysis on 15,196 patients","volume":"136","author":"Testa","year":"2008","journal-title":"J.\u00a0Thorac. Cardiovasc Surg."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib52","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jtcvs.2010.08.035","article-title":"PRIMO-CABG II Investigators. Effects of C5 complement inhibitor pexelizumab on outcome in high-risk coronary artery bypass grafting: combined results from the PRIMO-CABG I and II trials","volume":"142","author":"Smith","year":"2011","journal-title":"J.\u00a0Thorac. Cardiovasc Surg."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib53","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nri3479","article-title":"Newly described pattern recognition receptors team up against intracellular pathogens","volume":"13","author":"Broz","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib54","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1126\/science.1068883","article-title":"Decoding the patterns of self and nonself by the innate immune system","volume":"296","author":"Medzhitov","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib55","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1006\/smim.1998.0143","article-title":"An innate sense of danger","volume":"10","author":"Matzinger","year":"1998","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib56","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1007\/s00011-010-0208-2","article-title":"Important aspects of Toll-like receptors, ligands and their signaling pathways","volume":"59","author":"Chang","year":"2010","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib57","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/ni.1863","article-title":"The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors","volume":"11","author":"Kawai","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib58","doi-asserted-by":"crossref","first-page":"47834","DOI":"10.1074\/jbc.M207873200","article-title":"Lipopolysaccharide rapidly traffics to and from the Golgi apparatus with the toll-like receptor 4-MD-2-CD14 complex in a process that is distinct from the initiation of signal transduction","volume":"277","author":"Latz","year":"2002","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib59","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.cell.2006.03.047","article-title":"Phosphoinositide-mediated adaptor recruitment controls Toll-like receptor signaling","volume":"125","author":"Kagan","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib60","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/978-0-387-71767-8_4","article-title":"The journey of Toll-like receptors in the cell","volume":"598","author":"Halaas","year":"2007","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib61","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/ni1569","article-title":"TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-beta","volume":"9","author":"Kagan","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib62","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1074\/jbc.M114.593426","article-title":"A\u00a0role for the adaptor proteins TRAM and TRIF in toll-like receptor 2 signaling","volume":"290","author":"Nilsen","year":"2015","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib63","doi-asserted-by":"crossref","first-page":"31332","DOI":"10.1074\/jbc.M103217200","article-title":"Endocytosed HSP60s use toll-like receptor 2 (TLR2) and TLR4 to activate the toll\/interleukin-1 receptor signaling pathway in innate immune cells","volume":"276","author":"Vabulas","year":"2001","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib64","doi-asserted-by":"crossref","first-page":"7021","DOI":"10.4049\/jimmunol.176.11.7021","article-title":"Identification of small heat shock protein B8 (HSP22) as a novel TLR4 ligand and potential Involvement in the pathogenesis of rheumatoid arthritis","volume":"176","author":"Roelofs","year":"2006","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib65","doi-asserted-by":"crossref","first-page":"6318","DOI":"10.4049\/jimmunol.179.9.6318","article-title":"Hsp72 induces inflammation and regulates cytokine production in Airway Epithelium through a TLR4- and NF- b-dependent mechanism","volume":"179","author":"Chase","year":"2007","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib66","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.immuni.2006.12.005","article-title":"Heat shock protein gp96 is a master chaperone for toll-like receptors and is important in the innate function of macrophages","volume":"26","author":"Yang","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib67","doi-asserted-by":"crossref","first-page":"30393","DOI":"10.1074\/jbc.M111.266528","article-title":"Toll-like receptor 4 (TLR4) is essential for Hsp70-like protein 1 (HSP70L1) to activate dendritic cells and induce Th1 response","volume":"286","author":"Fang","year":"2011","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib68","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/01.shk.0000225404.51320.82","article-title":"HMGB1 signals through toll-like receptor (TLR) 4 and TLR2","volume":"26","author":"Yu","year":"2006","journal-title":"Shock"},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib69","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1189\/jlb.0908548","article-title":"The alarmin HMGB1 acts in synergy with endogenous and exogenous danger signals to promote inflammation","volume":"86","author":"Hreggvidsdottir","year":"2009","journal-title":"J.\u00a0Leukoc. Biol."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib70","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.atherosclerosis.2011.11.039","article-title":"HMGB1 signals danger in acute coronary syndrome: emergence of a new risk marker for cardiovascular death?","volume":"221","author":"Peter","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib71","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1161\/01.ATV.0000226553.01555.02","article-title":"Oxidized low-density lipoprotein correlates positively with toll-like receptor 2 and interferon regulatory factor-1 and inversely with superoxide dismutase-1 expression: studies in hypercholesterolemic swine and THP-1 cells","volume":"26","author":"Holvoet","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib72","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/ni.1836","article-title":"CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer","volume":"11","author":"Stewart","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib73","doi-asserted-by":"crossref","first-page":"14008","DOI":"10.3390\/ijms140714008","article-title":"Toll-like receptors in atherosclerosis","volume":"14","author":"Falck-Hansen","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib74","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1189\/jlb.0304127","article-title":"Endogenous ligands of Toll-like receptors","volume":"76","author":"Tsan","year":"2004","journal-title":"J.\u00a0Leukoc. Biol."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib75","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.immuni.2011.05.006","article-title":"Toll-like receptors and their crosstalk with other innate receptors in infection and immunity","volume":"34","author":"Kawai","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib76","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nri3151","article-title":"Accessory molecules for toll-like receptors and their function","volume":"12","author":"Lee","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib77","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.atherosclerosis.2013.05.011","article-title":"CD14 and TLR4 mediate cytokine release promoted by electronegative LDL in monocytes","volume":"229","author":"Estruch","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib78","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nri3452","article-title":"Activation and regulation of the inflammasomes","volume":"13","author":"Latz","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib79","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/nature08938","article-title":"NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals","volume":"464","author":"Duewell","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib80","doi-asserted-by":"crossref","first-page":"e11765","DOI":"10.1371\/journal.pone.0011765","article-title":"Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: a novel link between cholesterol metabolism and inflammation","volume":"5","author":"Rajam\u00e4ki","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib81","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/ni.2639","article-title":"CD36 coordinates NLRP3 inflammasome activation by facilitating intracellular nucleation of soluble ligands into particulate ligands in sterile inflammation","volume":"14","author":"Sheedy","year":"2013","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib82","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1161\/CIRCULATIONAHA.112.122556","article-title":"Effects of Interleukin-1\u03b2 inhibition with canakinumab on Hemoglobin A1c, lipids, c-reactive protein, Interleukin-6, and Fibrinogen: a phase IIb randomized, placebo-controlled trial","volume":"126","author":"Ridker","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib83","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1038\/ni.2704","article-title":"Fatty acid-induced mitochondrial uncoupling elicits inflammasome-independent IL-1\u03b1 and sterile vascular inflammation in atherosclerosis","volume":"14","author":"Freigang","year":"2013","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib84","doi-asserted-by":"crossref","first-page":"ra11","DOI":"10.1126\/scisignal.2000697","article-title":"Microbial hijacking of complement-toll-like receptor crosstalk","volume":"3","author":"Wang","year":"2010","journal-title":"Sci. Signal"},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib85","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.it.2010.01.002","article-title":"Crosstalk pathways between Toll-like receptors and the complement system","volume":"31","author":"Hajishengallis","year":"2010","journal-title":"Trends Immunol."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib86","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1177\/0192623311428478","article-title":"Crosstalk between complement and toll-like receptors","volume":"40","author":"Song","year":"2012","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib87","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.imbio.2012.07.019","article-title":"Bride and groom in systemic inflammation\u2013the bells ring for complement and Toll in cooperation","volume":"217","author":"Barratt-Due","year":"2012","journal-title":"Immunobiology"},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib88","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.clim.2007.11.014","article-title":"Insoluble immune complexes are most effective at triggering IL-10 production in human monocytes and synergize with TLR ligands and C5a","volume":"127","author":"DiMartino","year":"2008","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib89","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/jb\/mvq136","article-title":"C5a controls TLR-induced IL-10 and IL-12 production independent of phosphoinositide 3-kinase","volume":"149","author":"Okazaki","year":"2011","journal-title":"J.\u00a0Biochem."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib90","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1002\/eji.201041350","article-title":"TLR activation enhances C5a-induced pro-inflammatory responses by negatively modulating the second C5a receptor, C5L2","volume":"41","author":"Raby","year":"2011","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib91","doi-asserted-by":"crossref","first-page":"e0117261","DOI":"10.1371\/journal.pone.0117261","article-title":"CD14 and complement crosstalk and Largely mediate the Transcriptional response to Escherichia coli in human whole blood as revealed by DNA microarray","volume":"10","author":"Lau","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib92","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1182\/blood-2006-12-063636","article-title":"Regulation of Toll-like receptor-mediated inflammatory response by complement in\u00a0vivo","volume":"110","author":"Zhang","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib93","doi-asserted-by":"crossref","first-page":"5625","DOI":"10.4049\/jimmunol.1301903","article-title":"Complement factor B is the downstream effector of TLRs and plays an important role in a mouse model of severe sepsis","volume":"191","author":"Zou","year":"2013","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib94","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/ni.1908","article-title":"Integrin CD11b negatively regulates TLR-triggered inflammatory responses by activating Syk and promoting degradation of MyD88 and TRIF via Cbl-b","volume":"11","author":"Han","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib95","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/ni0810-691","article-title":"Integrins limit the Toll","volume":"11","author":"Means","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib96","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1365-2044.2011.07011.x","article-title":"Complement takes its Toll: an inflammatory crosstalk between Toll-like receptors and the receptors for the complement anaphylatoxin C5a","volume":"67","author":"Holst","year":"2012","journal-title":"Anaesthesia"},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib97","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1242\/jcs.124388","article-title":"The complement membrane attack complex triggers intracellular Ca2+ fluxes leading to NLRP3 inflammasome activation","volume":"126","author":"Triantafilou","year":"2013","journal-title":"J.\u00a0Cell. Sci."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib98","doi-asserted-by":"crossref","first-page":"3473","DOI":"10.1182\/blood-2013-05-502229","article-title":"C3a modulates IL-1\u03b2 secretion in human monocytes by regulating ATP efflux and subsequent NLRP3 inflammasome activation","volume":"122","author":"Asgari","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib99","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.4049\/jimmunol.1302484","article-title":"Cholesterol crystals induce complement-dependent inflammasome activation and cytokine release","volume":"192","author":"Samstad","year":"2014","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib100","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.it.2007.02.006","article-title":"Complement and coagulation: strangers or partners in crime?","volume":"28","author":"Markiewski","year":"2007","journal-title":"Trends Immunol."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib101","doi-asserted-by":"crossref","first-page":"5628","DOI":"10.4049\/jimmunol.0903678","article-title":"Molecular intercommunication between the complement and coagulation systems","volume":"185","author":"Amara","year":"2010","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib102","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1160\/TH13-02-0102","article-title":"Crosstalk between platelets and the complement system in immune protection and disease","volume":"110","author":"Verschoor","year":"2013","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib103","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1172\/JCI58969","article-title":"Monocyte tissue factor-dependent activation of coagulation in hypercholesterolemic mice and monkeys is inhibited by simvastatin","volume":"122","author":"Owens","year":"2012","journal-title":"J.\u00a0Clin. Invest"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2015.05.038_bib104","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.molimm.2015.02.027","article-title":"The role of complement factor C3 in lipid metabolism","volume":"67","author":"Barbu","year":"2015","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib105","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nri2918","article-title":"Microbial manipulation of receptor crosstalk in innate immunity","volume":"11","author":"Hajishengallis","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib106","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.molcel.2014.03.010","article-title":"Bacteria fighting back: how pathogens target and subvert the host innate immune system","volume":"54","author":"Reddick","year":"2014","journal-title":"Mol. Cell."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib107","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1189\/jlb.0806538","article-title":"The role of complement C3 opsonization, C5a receptor, and CD14 in E. coli-induced up-regulation of granulocyte and monocyte CD11b\/CD18 (CR3), phagocytosis, and oxidative burst in human whole blood","volume":"81","author":"Brekke","year":"2007","journal-title":"J.\u00a0Leukoc. Biol."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib108","doi-asserted-by":"crossref","first-page":"3804","DOI":"10.1016\/j.molimm.2008.05.017","article-title":"Combined inhibition of complement and CD14 abolish E. coli-induced cytokine-, chemokine- and growth factor-synthesis in human whole blood","volume":"45","author":"Brekke","year":"2008","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib109","doi-asserted-by":"crossref","first-page":"e496","DOI":"10.1542\/peds.2007-0878","article-title":"Role of complement and CD14 in meconium-induced cytokine formation","volume":"121","author":"Salvesen","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib110","doi-asserted-by":"crossref","first-page":"819","DOI":"10.4049\/jimmunol.1201909","article-title":"Combined inhibition of complement (C5) and CD14 markedly attenuates inflammation, Thrombogenicity, and hemodynamic changes in porcine sepsis","volume":"191","author":"Barratt-Due","year":"2013","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib111","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1161\/CIRCRESAHA.113.300987","article-title":"Historical perspective on the pathology of myocardial ischemia\/reperfusion injury","volume":"113","author":"Jennings","year":"2013","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib112","doi-asserted-by":"crossref","first-page":"F801","DOI":"10.1152\/ajprenal.00469.2013","article-title":"Role of toll-like receptor-4 in renal graft ischemia-reperfusion injury","volume":"306","author":"Zhao","year":"2014","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib113","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/j.1600-6143.2011.03475.x","article-title":"Crosstalk between complement and toll-like receptor activation in relation to donor brain death and renal ischemia-reperfusion injury","volume":"11","author":"Damman","year":"2011","journal-title":"Am. J. Transpl."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib114","doi-asserted-by":"crossref","first-page":"578","DOI":"10.3389\/fimmu.2014.00578","article-title":"MicroRNA-146a: a dominant, negative regulator of the innate immune response","volume":"5","author":"Saba","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib115","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/1742-2094-11-97","article-title":"MiR-155 induction in microglial cells suppresses Japanese encephalitis virus replication and negatively modulates innate immune responses","volume":"11","author":"Pareek","year":"2014","journal-title":"J.\u00a0Neuroinflammation"},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib116","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/imm.12314","article-title":"Transcriptional profiling reveals that C5a alters microRNA in brain endothelial cells","volume":"143","author":"Eadon","year":"2014","journal-title":"Immunology"},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib117","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.atherosclerosis.2012.11.019","article-title":"MicroRNAs and lipoproteins: a connection beyond atherosclerosis?","volume":"227","author":"Norata","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib118","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1159\/000332435","article-title":"The role of complement in the development and manifestation of murine atherogenic inflammation: novel avenues","volume":"4","author":"Francescut","year":"2012","journal-title":"J.\u00a0Innate Immun."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib119","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1161\/CIRCRESAHA.108.191361","article-title":"Complement regulator CD59 protects against atherosclerosis by restricting the formation of complement membrane attack complex","volume":"104","author":"Wu","year":"2009","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib120","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1161\/01.ATV.18.11.1790","article-title":"Complement C6 deficiency protects against diet-induced atherosclerosis in rabbits","volume":"18","author":"Schmiedt","year":"1998","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib121","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1006\/bbrc.2001.5276","article-title":"ApoE(-\/-) mice develop atherosclerosis in the absence of complement component C5","volume":"286","author":"Patel","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib122","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0091-6749(80)90042-1","article-title":"In\u00a0vitro effects of radiographic contrast media on the complement system","volume":"66","author":"Hasselbacher","year":"1980","journal-title":"J.\u00a0Allergy Clin. Immunol."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib123","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.imbio.2014.06.006","article-title":"Cholesterol crystal-induced endothelial cell activation is complement-dependent and mediated by TNF","volume":"219","author":"Nymo","year":"2014","journal-title":"Immunobiology"},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib124","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1172\/JCI64617","article-title":"Treg-mediated suppression of atherosclerosis requires MYD88 signaling in DCs","volume":"123","author":"Subramanian","year":"2013","journal-title":"J.\u00a0Clin. Invest"},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib125","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1084\/jem.20131314","article-title":"MyD88-dependent interplay between myeloid and endothelial cells in the initiation and progression of obesity-associated inflammatory diseases","volume":"211","author":"Yu","year":"2014","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib126","doi-asserted-by":"crossref","first-page":"E345","DOI":"10.1073\/pnas.1414857111","article-title":"Mice are not men","volume":"112","author":"Warren","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib127","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nature10146","article-title":"Progress and challenges in translating the biology of atherosclerosis","volume":"473","author":"Libby","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib128","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1161\/01.ATV.19.10.2348","article-title":"Complement and atherogenesis : binding of CRP to Degraded, Nonoxidized LDL enhances complement activation","volume":"19","author":"Bhakdi","year":"1999","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib129","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1161\/01.CIR.0000124228.08972.26","article-title":"Possible protective role for C-reactive protein in atherogenesis: complement activation by modified lipoproteins halts before detrimental terminal sequence","volume":"109","author":"Bhakdi","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib130","doi-asserted-by":"crossref","first-page":"3932","DOI":"10.4049\/jimmunol.1002080","article-title":"Innate immune proteins C1q and mannan-binding lectin enhance clearance of atherogenic lipoproteins by human monocytes and macrophages","volume":"185","author":"Fraser","year":"2010","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib131","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.humimm.2010.05.005","article-title":"Activation of TLR2 and TLR4 by minimally modified low-density lipoprotein in human macrophages and monocytes triggers the inflammatory response","volume":"71","author":"Ch\u00e1vez-S\u00e1nchez","year":"2010","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib132","doi-asserted-by":"crossref","first-page":"12213","DOI":"10.1074\/jbc.M110.214619","article-title":"Oxidized low density lipoprotein induces bone morphogenetic protein-2 in coronary artery endothelial cells via Toll-like receptors 2 and 4","volume":"286","author":"Su","year":"2011","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib133","doi-asserted-by":"crossref","first-page":"6043","DOI":"10.4049\/jimmunol.1100967","article-title":"Hck tyrosine kinase regulates TLR4-induced TNF and IL-6 production via AP-1","volume":"187","author":"Smolinska","year":"2011","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib134","doi-asserted-by":"crossref","first-page":"5954","DOI":"10.1074\/jbc.M111.289322","article-title":"Modified low density lipoprotein stimulates complement C3 expression and secretion via liver X receptor and Toll-like receptor 4 activation in human macrophages","volume":"287","author":"Mogilenko","year":"2012","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib135","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.atherosclerosis.2006.12.016","article-title":"Receptors for the anaphylatoxins C3a and C5a are expressed in human atherosclerotic coronary plaques","volume":"195","author":"Oksjoki","year":"2007","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib136","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1016\/j.ajpath.2014.04.004","article-title":"High expression of C5L2 correlates with high proinflammatory cytokine expression in advanced human atherosclerotic plaques","volume":"184","author":"Vijayan","year":"2014","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib137","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.atherosclerosis.2007.03.040","article-title":"Complement system is activated in stenotic aortic valves","volume":"196","author":"Helske","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib138","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1365-2362.2009.02216.x","article-title":"Activated complement is more extensively present in diseased aortic valves than naturally occurring complement inhibitors: a sign of ongoing inflammation","volume":"40","author":"ter Weeme","year":"2010","journal-title":"Eur. J. Clin. Invest"},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib139","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1161\/hc5001.100631","article-title":"Toll-like Receptor-4 is expressed by macrophages in murine and human lipid-rich atherosclerotic plaques and upregulated by oxidized LDL","volume":"104","author":"Xu","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib140","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1161\/circ.105.10.1158","article-title":"Expression of toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation","volume":"105","author":"Edfeldt","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib141","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s00011-013-0697-x","article-title":"Wnt5a, TLR2 and TLR4 are elevated in advanced human atherosclerotic lesions","volume":"63","author":"Malgor","year":"2014","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib142","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1084\/jem.20071096","article-title":"Increased endothelial expression of Toll-like receptor 2 at sites of disturbed blood flow exacerbates early atherogenic events","volume":"205","author":"Mullick","year":"2008","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib143","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.immuni.2013.06.009","article-title":"Immune effector mechanisms implicated in atherosclerosis: from mice to humans","volume":"38","author":"Libby","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib144","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1097\/01.hjr.0000224485.80349.76","article-title":"The third component of the complement (C3) is a marker of the risk of atherogenesis","volume":"13","author":"Capuano","year":"2006","journal-title":"Eur. J. Cardiovasc Prev. Rehabil."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib145","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1097\/01.hjr.0000244582.30421.b2","article-title":"Complement C3 and C4 in plasma and incidence of myocardial infarction and stroke: a population-based cohort study","volume":"14","author":"Engstr\u00f6m","year":"2007","journal-title":"Eur. J. Cardiovasc Prev. Rehabil."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib146","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/j.1365-2362.2010.02418.x","article-title":"The cross-sectional association between insulin resistance and circulating complement C3 is partly explained by plasma alanine aminotransferase, independent of central obesity and general inflammation (the CODAM study)","volume":"41","author":"van Greevenbroek","year":"2011","journal-title":"Eur. J. Clin. Invest"},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib147","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1016\/j.metabol.2012.05.015","article-title":"Low-grade inflammation and insulin resistance independently explain substantial parts of the association between body fat and serum C3: the CODAM study","volume":"61","author":"Wlazlo","year":"2012","journal-title":"Metabolism"},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib148","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/eci.12275","article-title":"C3 and C4 are strongly related to Adipose tissue variables and cardiovascular risk factors","volume":"44","author":"Nilsson","year":"2014","journal-title":"Eur. J. Clin. Invest"},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib149","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.amjcard.2006.11.034","article-title":"Serum complement C3\/C4 ratio, a novel marker for recurrent cardiovascular events","volume":"99","author":"Palikhe","year":"2007","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib150","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1160\/TH13-10-0831","article-title":"Distinct associations of complement C3a and its precursor C3 with atherosclerosis and cardiovascular disease. The CODAM study","volume":"111","author":"Hertle","year":"2014","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib151","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.atherosclerosis.2014.12.002","article-title":"Expression of anaphylatoxin receptors on platelets in patients with coronary heart disease","volume":"238","author":"Patzelt","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib152","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1093\/eurheartj\/ehr377","article-title":"Ischaemia-induced up-regulation of Toll-like receptor 2 in circulating monocytes in cardiogenic shock","volume":"33","author":"Selejan","year":"2012","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib153","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.atherosclerosis.2011.06.020","article-title":"Myeloid related proteins activate Toll-like receptor 4 in human acute coronary syndromes","volume":"218","author":"Yonekawa","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib154","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ijcard.2005.06.023","article-title":"Activated toll-like receptor 4 in monocytes is associated with heart failure after acute myocardial infarction","volume":"109","author":"Satoh","year":"2006","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib155","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.atherosclerosis.2011.12.030","article-title":"Differential expression of Toll-like receptor 4 and human monocyte subsets in acute myocardial infarction","volume":"221","author":"Kashiwagi","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib156","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1136\/hrt.2007.117259","article-title":"Monocyte toll-like receptor 2 and 4 responses and expression following percutaneous coronary intervention: association with lesion stenosis and fractional flow reserve","volume":"94","author":"Versteeg","year":"2008","journal-title":"Heart"},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib157","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.atherosclerosis.2013.09.036","article-title":"Increased cytokine response after toll-like receptor stimulation in patients with stable coronary artery disease","volume":"231","author":"Elsenberg","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib158","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/intimm\/dxm117","article-title":"Low complement C4B gene copy number predicts short-term mortality after acute myocardial infarction","volume":"20","author":"Blask\u00f3","year":"2008","journal-title":"Int. Immunol."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib159","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nrrheum.2011.75","article-title":"Epidemiology of CVD in rheumatic disease, with a focus on RA and SLE","volume":"7","author":"Symmons","year":"2011","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib160","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.molimm.2009.10.021","article-title":"Double role of mannose-binding lectin in relation to carotid intima-media thickness in patients with rheumatoid arthritis","volume":"47","author":"Troelsen","year":"2010","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib161","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.atherosclerosis.2010.11.041","article-title":"Mannose binding lectin 2 haplotypes do not affect the progression of coronary atherosclerosis in men with proven coronary artery disease treated with pravastatin","volume":"215","author":"Alipour","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib162","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1475-2840-10-60","article-title":"Low Mannose-Binding Lectin (MBL) genotype is associated with future cardiovascular events in type 2 diabetic South Asians. A prospective cohort study","volume":"10","author":"Siezenga","year":"2011","journal-title":"Cardiovasc Diabetol."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib163","doi-asserted-by":"crossref","first-page":"e42113","DOI":"10.1371\/journal.pone.0042113","article-title":"Mannose-binding lectin deficiency is associated with myocardial infarction: the HUNT2 study in Norway","volume":"7","author":"Vengen","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib164","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1056\/NEJMoa033122","article-title":"Mannose-binding lectin variant alleles and the risk of arterial thrombosis in systemic lupus erythematosus","volume":"351","author":"\u00d8hlenschlaeger","year":"2004","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib165","doi-asserted-by":"crossref","first-page":"911","DOI":"10.2337\/dc11-1642","article-title":"Complement activation and prognosis in patients with type 2 diabetes and myocardial infarction: a report from the DIGAMI 2 trial","volume":"35","author":"Mellbin","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib166","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/cei.12093","article-title":"Plasma levels of mannan-binding lectin (MBL)-associated serine proteases (MASPs) and MBL-associated protein in cardio- and cerebrovascular diseases","volume":"173","author":"Frauenknecht","year":"2013","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib167","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1111\/j.1365-2362.2012.02669.x","article-title":"Polymorphism of the complement 5 gene and cardiovascular outcome in patients with atherosclerosis","volume":"42","author":"Hoke","year":"2012","journal-title":"Eur. J. Clin. Invest"},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib168","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.atherosclerosis.2012.08.029","article-title":"Complement system and small HDL particles are associated with subclinical atherosclerosis in SLE patients","volume":"225","author":"Parra","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib169","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.atherosclerosis.2010.07.021","article-title":"Genetic variation in complement factor H and risk of coronary heart disease: eight new studies and a meta-analysis of around 48,000 individuals","volume":"213","author":"Sofat","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib170","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1093\/eurheartj\/ehn568","article-title":"Complement factor H Y402H decreases cardiovascular disease risk in patients with familial hypercholesterolaemia","volume":"30","author":"Koeijvoets","year":"2009","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib171","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1161\/01.STR.0000260184.85257.2b","article-title":"Toll receptor polymorphisms and carotid artery intima-media thickness","volume":"38","author":"Labrum","year":"2007","journal-title":"Stroke"},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib172","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/jhg.2013.98","article-title":"Polymorphism -2604G>A variants in TLR4 promoter are associated with different gene expression level in peripheral blood of atherosclerotic patients","volume":"58","author":"Ferronato","year":"2013","journal-title":"J.\u00a0Hum. Genet."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib173","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/j.amjcard.2008.02.052","article-title":"Cholesterol ester transfer protein, interleukin-8, peroxisome proliferator activator receptor alpha, and Toll-like receptor 4 genetic variations and risk of incident nonfatal myocardial infarction and ischemic stroke","volume":"101","author":"Enquobahrie","year":"2008","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib174","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/j.1365-3083.2012.02681.x","article-title":"Association studies of gene polymorphisms in toll-like receptors 2 and 4 in croatian patients with acute myocardial infarction","volume":"75","author":"D\u017eumhur","year":"2012","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib175","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1161\/ATVBAHA.112.253179","article-title":"Immunization with a combination of 2 peptides derived from the C5a receptor significantly reduces early atherosclerotic lesion in Ldlrtm1Her Apobtm2SgyJ mice","volume":"32","author":"Lu","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib176","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1161\/CIRCULATIONAHA.110.954370","article-title":"C5a receptor targeting in neointima formation after arterial injury in atherosclerosis-prone mice","volume":"122","author":"Shagdarsuren","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib177","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.athoracsur.2003.08.054","article-title":"Pexelizumab study Investigators. Impact of pexelizumab, an anti-C5 complement antibody, on total mortality and adverse cardiovascular outcomes in cardiac surgical patients undergoing cardiopulmonary bypass","volume":"77","author":"Shernan","year":"2004","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib178","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1001\/jama.291.19.2319","article-title":"PRIMO-CABG Investigators. Terminal complement blockade with pexelizumab during coronary artery bypass graft surgery requiring cardiopulmonary bypass: a randomized trial","volume":"291","author":"Verrier","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib179","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1001\/jama.297.1.43","article-title":"Pexelizumab for acute ST-elevation myocardial infarction in patients undergoing primary percutaneous coronary intervention: a randomized controlled trial","volume":"297","author":"Armstrong","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib180","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.ahj.2006.03.027","article-title":"Effect of pexelizumab on mortality in patients with acute myocardial infarction or undergoing coronary artery bypass surgery: a systematic overview","volume":"152","author":"Mahaffey","year":"2006","journal-title":"Am. Heart J."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib181","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ahj.2012.04.007","volume":"164","author":"Martel","year":"2012","journal-title":"Am. Heart J."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib182","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/cei.12212","article-title":"VB-201, an oxidized phospholipid small molecule, inhibits CD14- and Toll-like receptor-2-dependent innate cell activation and constrains atherosclerosis","volume":"175","author":"Mendel","year":"2014","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib183","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/nri2873","article-title":"Sterile inflammation: sensing and reacting to damage","volume":"10","author":"Chen","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib184","first-page":"253","article-title":"Hypothesis: combined inhibition of complement and CD14 as treatment regimen to attenuate the inflammatory response","volume":"632","author":"Mollnes","year":"2008","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib185","doi-asserted-by":"crossref","first-page":"416","DOI":"10.2353\/ajpath.2007.060406","article-title":"Complement C1q reduces early atherosclerosis in low-density lipoprotein receptor-deficient mice","volume":"170","author":"Bhatia","year":"2007","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib186","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1161\/CIRCULATIONAHA.109.868158","article-title":"Immunoglobulin M is required for protection against atherosclerosis in low-density lipoprotein receptor-deficient mice","volume":"120","author":"Lewis","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib187","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1161\/CIRCULATIONAHA.108.830661","article-title":"Macrophage-specific expression of mannose-binding lectin controls atherosclerosis in low-density lipoprotein receptor-deficient mice","volume":"119","author":"Matthijsen","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib188","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1161\/CIRCULATIONAHA.112.103051","article-title":"Targeting mannose-binding lectin confers long-lasting protection with a surprisingly wide therapeutic window in cerebral ischemia","volume":"126","author":"Orsini","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib189","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1161\/CIRCULATIONAHA.110.981365","article-title":"The alternative pathway is critical for pathogenic complement activation in endotoxin- and diet-induced atherosclerosis in low-density lipoprotein receptor-deficient mice","volume":"122","author":"Malik","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib190","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1096\/fj.10-174284","article-title":"Complement C5a inhibition reduces atherosclerosis in ApoE\u2212\/\u2212 mice","volume":"25","author":"Manthey","year":"2011","journal-title":"FASEB J."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib191","doi-asserted-by":"crossref","DOI":"10.1161\/ATVBAHA.110.205559","article-title":"The Intrinsic complement regulator decay-accelerating factor modulates the biological response to vascular injury","volume":"30","author":"Sakuma","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib192","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/j.ajpath.2011.06.015","article-title":"CD55 deficiency protects against atherosclerosis in ApoE-deficient mice via C3a modulation of lipid metabolism","volume":"179","author":"Lewis","year":"2011","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib193","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.atherosclerosis.2014.03.004","article-title":"Targeted mouse complement inhibitor CR2-Crry protects against the development of atherosclerosis in mice","volume":"234","author":"Liu","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib194","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1161\/CIRCULATIONAHA.108.793869","article-title":"Increased inflammatory gene expression in ABC transporter-deficient macrophages: free cholesterol accumulation, increased signaling via toll-like receptors, and neutrophil infiltration of atherosclerotic lesions","volume":"118","author":"Yvan-Charvet","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib195","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1159\/000303052","article-title":"Toll-like receptor 4 signaling mediates inflammatory activation induced by C-reactive protein in vascular smooth muscle cells","volume":"25","author":"Liu","year":"2010","journal-title":"Cell. Physiology Biochem."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib196","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1161\/ATVBAHA.112.249847","article-title":"Toll-like receptor 4 deficiency decreases atherosclerosis but does not protect against inflammation in obese low-density lipoprotein receptor-deficient mice","volume":"32","author":"Ding","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib197","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.4049\/jimmunol.1201541","article-title":"Protective role for TLR4 signaling in atherosclerosis progression as revealed by infection with a common oral pathogen","volume":"189","author":"Hayashi","year":"2012","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib198","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1194\/jlr.M028431","article-title":"Atherosclerosis induced by endogenous and exogenous toll-like receptor (TLR)1 or TLR6 agonists","volume":"53","author":"Curtiss","year":"2012","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib199","doi-asserted-by":"crossref","first-page":"e72","DOI":"10.1161\/ATVBAHA.112.249391","article-title":"Blocking toll-like receptors 7 and 9 reduces postinterventional remodeling via reduced macrophage activation, foam cell formation, and migration","volume":"32","author":"Karper","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib200","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1161\/CIRCULATIONAHA.112.100339","article-title":"Conditional targeting of tumor necrosis factor receptor-associated factor 6 reveals opposing functions of toll-like receptor signaling in endothelial and myeloid cells in a mouse model of atherosclerosis","volume":"126","author":"Polykratis","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2015.05.038_bib201","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1161\/ATVBAHA.113.302407","article-title":"Protective role for toll-like receptor-9 in the development of atherosclerosis in apolipoprotein E-deficient mice","volume":"34","author":"Koulis","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002191501501357X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002191501501357X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,26]],"date-time":"2019-08-26T09:23:57Z","timestamp":1566811437000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002191501501357X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":201,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S002191501501357X"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2015.05.038","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The complement system and toll-like receptors as integrated players in the pathophysiology of atherosclerosis","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2015.05.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}